4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-20-000008
Chief Executive Officer gave up 65,068 shares (to pay taxes)
- Chief Executive Officer acquired 183,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kim Jong Joseph · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-05 | Exercise or conversion : show line 1 in the form | +120,100 | 1,220,807 | D | ||
| 2020-03-05 | Shares withheld for taxes : show line 2 in the form | −37,371 | $9.80 | $366,236 | 1,183,436 | D |
| 2020-03-08 | Exercise or conversion : show line 3 in the form | +63,700 | 1,247,136 | D | ||
| 2020-03-08 | Shares withheld for taxes : show line 4 in the form | −27,697 | $14.09 | $390,251 | 1,219,439 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-03-05 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −120,100 | 120,100 | 120,100 | D |
| 2020-03-08 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −63,700 | 63,700 | 127,400 | D |
Loading xslF345X03/wf-form4_158378508254040.xml…